Archives

THE SAGE GROUP LLC Announces that Mary L. Yost, President, will Lecture on Peripheral Arterial Disease (PAD) at the 2014 National Congress of Angiology and Vascular Surgery in Mexico.

In Recognition of National Peripheral Artery Disease (PAD) Awareness Month, THE SAGE GROUP Comments on the Costs and Consequences of the Disease.

THE SAGE GROUP Estimates the Economic Cost of Critical Limb Ischemia Amputations at $25 Billion.

THE SAGE GROUP LLC Announces Publication of an Article Titled “Cost-Benefit Analysis of Amputation in the Era of the Affordable Care Act. Is it Fiscally Responsible to Perform Primary Amputation as Treatment?” in the May Issue of Endovascular Today.

In Recognition of National Diabetes Month, THE SAGE GROUP LLC Highlights the Interrelationships Between Peripheral Artery Disease (PAD) and Diabetes, Diabetic Foot Ulcers (DFU) and Amputation.

In Recognition of National Peripheral Artery Disease (PAD) Awareness Month, THE SAGE GROUP Comments on the Costs and Consequences of the Disease.

According to THE SAGE GROUP Peripheral Artery Disease Amputations are Costly for the Economy, the Hospital and for the Patient.

THE SAGE GROUP Reports that Approximately 14 Million People in South America Suffer from Peripheral Artery Disease.

THE SAGE GROUP LLC Announces that Mary L. Yost, President, will Lecture on Socioeconomics of Amputation at the Save A Leg Save A Life Foundation Annual National Conference.

THE SAGE GROUP LLC Announces that Mary L. Yost, President, is a Featured Panelist in the Medscape Program Titled “The Price of PAD: The Clinical and Economic Consequences of Amputation.”

In Recognition of National Peripheral Artery Disease (PAD) Awareness Month, THE SAGE GROUP Comments on Current Knowledge and Treatment of the Disease.

THE SAGE GROUP LLC Celebrates its Tenth Anniversary as the Leading Research and Consulting Company Specializing in Peripheral Artery Disease and Critical Limb Ischemia.

THE SAGE GROUP LLC Announces that Mary L. Yost, President, will Lecture on Peripheral Artery Disease (PAD) Prevalence and Economics at the NEW CARDIOVASCULAR HORIZONS Conference.

THE SAGE GROUP Announces Publication of Peripheral Artery Disease Coding and Reimbursement Featuring an Overview of the Upcoming ICD-10 Diagnosis and Procedure Codes.

According to THE SAGE GROUP the Total Annual Economic Burden of Peripheral Artery Disease (PAD) in the U.S. Exceeds $300 Billion.